<?xml version="1.0" encoding="UTF-8"?>
<ref id="bph15092-bib-0083">
 <mixed-citation publication-type="journal" id="bph15092-cit-0084">
  <string-name>
   <surname>Safy‐Khan</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Jacobs</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>de Hair</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Welsing</surname>, 
   <given-names>P.</given-names>
  </string-name>, 
  <string-name>
   <surname>Edwardes</surname>, 
   <given-names>M. D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Teitsma</surname>, 
   <given-names>X. M.</given-names>
  </string-name>, … 
  <string-name>
   <surname>Bijlsma</surname>, 
   <given-names>J.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy</article-title>. 
  <source xml:lang="en">Annals of the Rheumatic Diseases</source>, 
  <volume>79</volume>(
  <issue>4</issue>), 
  <fpage>460</fpage>–
  <lpage>463</lpage>. 
  <pub-id pub-id-type="doi">10.1136/annrheumdis-2019-216537</pub-id>
  <pub-id pub-id-type="pmid">32033935</pub-id>
 </mixed-citation>
</ref>
